Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (vol 395, pg e30, 2020)

被引：1
作者：
Richardson, Peter
Griffin, Ivan
Tucker, Catherine
Smith, Dan
Oechsle, Olly
Phelan, Anne
Rawling, Michael [1 ]
Savory, Edward [1 ]
Stebbing, Justin
机构：
[1] BenevolentAI, London, England
来源：
LANCET | 2020年 / 395卷 / 10241期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1906 / 1906
页数：1
相关论文
共 45 条
  • [41] High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study (vol 14, pg 1229, 2019)
    Sun, Jiayan
    Li, Yujie
    Ling, Bingyu
    Zhu, Qingcheng
    Hu, Yingying
    Tan, Dingyu
    Geng, Ping
    Xu, Jun
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 1567 - 1567
  • [42] Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study (vol 7, pg e537, 2022)
    Luo, Q.
    O'Connell, D. L.
    Yu, X. Q.
    LANCET PUBLIC HEALTH, 2022, 7 (11) : E895 - E895
  • [43] Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (vol 32, pg 345, 2019)
    Pfeifer, H.
    Cazzaniga, G.
    van der Velden, V. H. J.
    Cayuela, J. M.
    Schafer, B.
    Spinelli, O.
    Akiki, S.
    Avigad, S.
    Bendit, I.
    Borg, K.
    Cave, H.
    Elia, L.
    Reshmi, S. C.
    Gerrard, G.
    Hayette, S.
    Hermanson, M.
    Juh, A.
    Jurcek, T.
    Chillon, M. C.
    Homburg, C.
    Martinelli, G.
    Kairisto, V.
    Lange, T.
    Lion, T.
    Mueller, M. C.
    Pane, F.
    Rai, L.
    Damm-Welk, C.
    Sacha, T.
    Schnittger, S.
    Touloumenidou, T.
    Valerhaugen, H.
    Vandenberghe, P.
    Zuna, J.
    Serve, H.
    Herrmann, E.
    Markovic, S.
    van Dongen, J. J. M.
    Ottmann, O. G.
    LEUKEMIA, 2020, 34 (07) : 1970 - 1970
  • [44] Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial (vol 7, pg e100, 2020)
    Walker, I
    Panzarella, T.
    Couban, S.
    LANCET HAEMATOLOGY, 2020, 7 (03): : E191 - E191
  • [45] Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-United States, 1 January 2022 to 31 March 2022 (vol 76, pg 1753, 2023)
    Kompaniyets, Lyudmyla
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (02) : 334 - 334
12345